Polyarteritis nodosa is a necrotizing vasculitis of medium-sized arteries.

It can involve the eye in a sizable share of patients, so the ophthalmologist may be the first to see signs of the disease.


What Polyarteritis Nodosa Is

The Chapel Hill consensus defines it as necrotizing arteritis of medium or small arteries without glomerulonephritis, and it is not linked to antineutrophil cytoplasmic antibodies.

It also affects the skin, nerves, kidneys and gut, and as a result it presents with varied systemic signs.

Causes of Polyarteritis Nodosa

Many cases are idiopathic, while hepatitis B infection is a classic trigger. Also, a monogenic form called deficiency of adenosine deaminase 2 mimics the disease in children, so test for infection and genetics where relevant.

Test your knowledge 10 questions from this article
Choroida · Fundus imaging

Fundus Explorer Pro

Photograph the retinal findings described here with the phone already in your pocket — 22 D optics and built-in illumination in one handheld unit.

From Choroida — the team behind this site

Systemic Features of Polyarteritis Nodosa

Patients have fever, weight loss and myalgia, and livedo reticularis, nodules and mononeuritis multiplex are common. Hypertension and renal infarcts also occur, and abdominal pain can signal mesenteric ischemia.

How Often the Eye Is Involved

Akova and colleagues found ocular signs in a considerable share of patients with polyarteritis nodosa. Rothschild and colleagues found ocular signs at diagnosis in a minority of patients with systemic necrotizing vasculitis. The eye may also be the first site, so ocular findings can lead the diagnosis.

Choroidal Vasculopathy

Occlusion of choroidal arteries causes patchy infarcts, and fluorescein angiography shows delayed filling and hypofluorescent areas. Serous detachment of the retina can also follow, so patients may notice central blur.

Retinal Vasculitis

Retinal vessels show sheathing, hemorrhages and cotton-wool spots, and branch occlusion can occur. Neovascularization may also follow ischemia (see retinal vasculitis), so angiography is needed to map the damage.

Hypertensive Retinopathy and Choroidopathy

Renal involvement can cause severe hypertension, and the retina may show hypertensive changes with exudates and disc swelling. Choroidal infarcts may also mimic vasculitic lesions, so check the blood pressure at every visit.

Anterior Segment and Orbit

Peripheral ulcerative keratitis and scleritis are well known in vasculitis, while orbital inflammation and optic neuropathy occur less often. These signs also signal active disease, so anterior findings should prompt a systemic review.

Differential Diagnosis

Giant cell arteritis causes ischemic optic neuropathy and choroidal ischemia in older patients, while granulomatosis with polyangiitis shows scleritis and orbital disease. Lupus and antiphospholipid syndrome also produce similar fundus signs, so serology and imaging help.

Diagnosing Polyarteritis Nodosa

Biopsy of an affected tissue or angiography of visceral vessels confirms the diagnosis, and aneurysms in renal or mesenteric arteries are typical. Blood tests also show high inflammatory markers, and you should test for hepatitis B.

Polyarteritis Nodosa: Retinal and Choroidal Disease

Ophthalmic Workup

Perform dilated examination, OCT and fluorescein angiography, and indocyanine angiography shows choroidal involvement. Also check visual fields in optic nerve disease, so the eye work-up documents extent and activity.

Treatment of Polyarteritis Nodosa

High-dose steroids are the first step, and cyclophosphamide is added for severe or organ-threatening disease. Also treat hepatitis B-related disease with antivirals and plasma exchange, so treatment depends on the cause.

Treatment of Polyarteritis Nodosa of Ocular Disease

Systemic therapy usually controls the eye, while laser or anti-VEGF drugs treat neovascularization and edema. Steroid injections may also help macular edema, and follow with angiography.

Prognosis of Polyarteritis Nodosa

Early treatment improves survival and organ outcomes, and eye involvement signals severe disease. Vision loss can also be permanent after infarcts, so quick recognition matters.

Follow-Up

Monitor disease activity with symptoms, markers and imaging, because relapses occur, especially after tapering. Also repeat eye examinations during follow-up, and coordinate with the rheumatologist.

Pitfalls to Avoid

  • Do not miss systemic disease behind an unexplained choroidopathy
  • Never attribute all findings to hypertension
  • Do not start steroids without a plan for the systemic workup
  • Never forget to test for hepatitis B

Pediatric Disease and DADA2

Children with a PAN-like illness may have mutations in the ADA2 gene, and they show strokes, fever and skin changes. Anti-TNF therapy also helps, so consider genetic testing in early-onset disease.

Imaging Pattern in Choroidal Infarcts

Indocyanine angiography shows hypofluorescent patches that match the lobular pattern, while fluorescein shows early hypofluorescence and late staining. OCT also shows serous fluid and thickening, so the pattern separates vasculitis from other choroidopathies.

Medication Monitoring

Cyclophosphamide and steroids need laboratory monitoring, so watch for infection, bone loss and cataract. Also check eye pressure on steroids, since eye and systemic reviews go together.


All-fit smartphone adapter on a slit lampFundus Explorer Pro smartphone fundus camera
Choroida · Clinical imaging

Document what you see

Two smartphone imaging tools built for everyday clinic use — one for the slit lamp, one for the fundus.

From Choroida — the team behind this site

References

  1. Akova YA, Jabbur NS, Foster CS. Ocular presentation of polyarteritis nodosa: clinical course and management with steroid and cytotoxic therapy. Ophthalmology. 1993;100:1775-1781.
  2. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheum. 2013;65:1-11.
  3. Pagnoux C, Seror R, Henegar C, et al. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum. 2010;62:616-626.
  4. Rothschild PR, Pagnoux C, Seror R, et al. Ophthalmologic manifestations of systemic necrotizing vasculitides at diagnosis: a retrospective study of 1286 patients and review of the literature. Semin Arthritis Rheum. 2013;42:507-514.

Test yourself

A few questions straight from this article.

1 / 10 0 correct
  1. How does the Chapel Hill consensus define polyarteritis nodosa?

Ahmed Ophthalmologist

Writes and reviews the clinical articles on Educate. Every post is checked against peer-reviewed sources before it goes live.